NCT05999292View on ClinicalTrials.gov

Phase 1 Study of 68Ga-R8760

PHASE1TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

May 23, 2024

Study Completion Date

May 23, 2024

Conditions
Adrenocortical Carcinoma
Interventions
DRUG

68Ga-R8760 injection at pre-defined dose levels

PET/CT imaging at predefined timepoints

DRUG

68Ga-R8760 injection

PET/CT imaging at a single timepoint

Trial Locations (2)

48109

University of Michigan Nuclear Medicine, Ann Arbor

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Radionetics Oncology

INDUSTRY

NCT05999292 - Phase 1 Study of 68Ga-R8760 | Biotech Hunter | Biotech Hunter